Ionis Pharmaceuticals Inc (FRA:ISI)
€ 33.48 -0.13 (-0.39%) Market Cap: 5.40 Bil Enterprise Value: 4.42 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 60/100

Ionis Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 17, 2023 / 03:00PM GMT
Release Date Price: €33.63 (-0.50%)
Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst

Good morning, everyone. Thanks for joining the 22nd Annual Needham Healthcare Conference. My name is Jerry Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Ionis Pharmaceuticals. Joining us today from Ionis is Head of Investor Relations, Wade Walk. (Operator Instructions) So with that, we'll get started. Wade, thank you so much for joining us today.

Wade Walke

Thank you, and thanks for having us here today. I appreciate being here.

Questions & Answers

Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst

Yes. So Ionis, it's been one of the leaders in developing RNA-targeted therapeutics for a long time. Just wondering if you could give us your perspective on the past, the present and the future of Ionis' ASO approach.

Wade Walke

You bet. Happy to. I actually joined Ionis over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot